A detailed history of Pinnacle Financial Partners Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Pinnacle Financial Partners Inc holds 175,654 shares of ABBV stock, worth $30 Million. This represents 0.71% of its overall portfolio holdings.

Number of Shares
175,654
Previous 171,213 2.59%
Holding current value
$30 Million
Previous $29.4 Million 18.12%
% of portfolio
0.71%
Previous 0.63%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$163.84 - $199.33 $727,613 - $885,224
4,441 Added 2.59%
175,654 $34.7 Million
Q2 2024

Aug 06, 2024

SELL
$154.79 - $180.76 $153,706 - $179,494
-993 Reduced 0.58%
171,213 $29.4 Million
Q1 2024

Apr 30, 2024

BUY
$159.82 - $182.1 $392,677 - $447,419
2,457 Added 1.45%
172,206 $31.4 Million
Q4 2023

Jan 22, 2024

SELL
$137.6 - $154.97 $201,033 - $226,411
-1,461 Reduced 0.85%
169,749 $26.3 Million
Q3 2023

Nov 03, 2023

SELL
$133.59 - $154.65 $32,061 - $37,116
-240 Reduced 0.14%
171,210 $25.5 Million
Q2 2023

Aug 07, 2023

BUY
$132.51 - $164.9 $150,531 - $187,326
1,136 Added 0.67%
171,450 $23.1 Million
Q1 2023

Apr 26, 2023

BUY
$144.61 - $166.54 $1.86 Million - $2.14 Million
12,852 Added 8.16%
170,314 $27.1 Million
Q4 2022

Feb 03, 2023

BUY
$138.31 - $165.87 $740,926 - $888,565
5,357 Added 3.52%
157,462 $25.5 Million
Q3 2022

Oct 31, 2022

BUY
$134.21 - $153.93 $607,031 - $696,225
4,523 Added 3.06%
152,105 $20.4 Million
Q2 2022

Jul 29, 2022

BUY
$137.62 - $174.96 $531,626 - $675,870
3,863 Added 2.69%
147,582 $22.6 Million
Q1 2022

May 02, 2022

SELL
$131.98 - $163.75 $379,310 - $470,617
-2,874 Reduced 1.96%
143,719 $23.3 Million
Q4 2021

Feb 01, 2022

BUY
$107.43 - $135.93 $270,079 - $341,728
2,514 Added 1.74%
146,593 $19.8 Million
Q3 2021

Oct 26, 2021

BUY
$106.4 - $120.78 $768,952 - $872,877
7,227 Added 5.28%
144,079 $15.5 Million
Q2 2021

Jul 21, 2021

BUY
$105.21 - $117.21 $2.75 Million - $3.06 Million
26,126 Added 23.6%
136,852 $15.4 Million
Q1 2021

Apr 19, 2021

BUY
$102.3 - $112.62 $167,874 - $184,809
1,641 Added 1.5%
110,726 $12 Million
Q4 2020

Jan 13, 2021

SELL
$80.49 - $108.67 $164,843 - $222,556
-2,048 Reduced 1.84%
109,085 $11.6 Million
Q3 2020

Oct 27, 2020

BUY
$85.91 - $100.83 $126,201 - $148,119
1,469 Added 1.34%
111,133 $9.73 Million
Q2 2020

Jul 28, 2020

BUY
$73.37 - $98.18 $321,140 - $429,733
4,377 Added 4.16%
109,664 $10.8 Million
Q1 2020

Apr 16, 2020

BUY
$64.5 - $97.79 $84,817 - $128,593
1,315 Added 1.26%
105,287 $8.02 Million
Q4 2019

Feb 06, 2020

SELL
$72.13 - $90.25 $56,622 - $70,846
-785 Reduced 0.75%
103,972 $9.21 Million
Q3 2019

Oct 25, 2019

BUY
$62.98 - $75.72 $337,005 - $405,177
5,351 Added 5.38%
104,757 $7.93 Million
Q2 2019

Aug 13, 2019

SELL
$65.7 - $83.98 $553,259 - $707,195
-8,421 Reduced 7.81%
99,406 $7.23 Million
Q1 2019

May 02, 2019

BUY
$77.14 - $90.79 $488,373 - $574,791
6,331 Added 6.24%
107,827 $8.69 Million
Q4 2018

Feb 04, 2019

SELL
$77.85 - $96.01 $491,934 - $606,687
-6,319 Reduced 5.86%
101,496 $9.36 Million
Q3 2018

Oct 31, 2018

BUY
$88.91 - $98.84 $63,570 - $70,670
715 Added 0.67%
107,815 $10.2 Million
Q2 2018

Jul 27, 2018

BUY
$89.78 - $106.23 $245,727 - $290,751
2,737 Added 2.62%
107,100 $9.92 Million
Q1 2018

May 03, 2018

SELL
$92.01 - $123.21 $864,617 - $1.16 Million
-9,397 Reduced 8.26%
104,363 $9.88 Million
Q4 2017

Feb 08, 2018

BUY
$89.56 - $98.21 $64,572 - $70,809
721 Added 0.64%
113,760 $11 Million
Q3 2017

Nov 08, 2017

BUY
$69.85 - $89.22 $7.9 Million - $10.1 Million
113,039
113,039 $10 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $302B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Pinnacle Financial Partners Inc Portfolio

Follow Pinnacle Financial Partners Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinnacle Financial Partners Inc, based on Form 13F filings with the SEC.

News

Stay updated on Pinnacle Financial Partners Inc with notifications on news.